Design and synthesis of novel 20(S)-α-aminophosphonate derivatives of camptothecin as potent antitumor agents
Yu-Yuan Chen,Yin-Peng Bai,Bin Li,Xiao-Bo Zhao,Cheng-Jie Yang,Ying-Qian Liu,Jian-Mei Gao,Jun Guo,Chun Li,Jing-Wen Peng,Zhong-Min Zhao,Zhi-Jun Zhang,Chuan-Rui Xu
DOI: https://doi.org/10.1016/j.bioorg.2021.105065
IF: 5.307
2021-09-01
Bioorganic Chemistry
Abstract:<p>29 novel 20(<em>S</em>)-aminophosphonate derivatives of camptothecin were synthesized via a FeCl<sub>3</sub> - catalyzed one-pot reaction. All of these compounds displayed similar or superior cytotoxic activity in comparison with that of <strong>Irinotecan</strong> against Hep3B, MCF-7, A-549, MDA-MB-231, KB, and multidrug-resistant (MDR) KB-vin cell lines. Out of them, compound <strong>B07</strong> exhibited significant cytotoxicity and 10-fold improvement in activity compared to <strong>Irinotecan</strong>. Mechanistically, <strong>B07</strong> not only induced cell apoptosis and cell cycle arrest in Hep3B and MCF-7 cells, but also inhibited Topoisomerase I activity in the cell and cell-free system in a manner similar to that of <strong>Irinotecan</strong>. In both xenograft and primary HCC mouse models, <strong>B07</strong> showed significant anti-tumor activity and was more potent than <strong>Irinotecan</strong>. Additionally, the acute toxicity assay showed that <strong>B07</strong> had no apparent toxicity to the mouse liver, kidney, and hemopoietic system of the FVB/N mice. Therefore, these findings indicate that compound <strong>B07</strong> could be a potential Topoisomerase I poison drug candidate for further clinical trial.</p>
biochemistry & molecular biology,chemistry, organic